Congenital anomalies after prenatal ecstasy exposure.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 10543673.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15.4% [95% CI 8.2-25.4]). Cardiovascular anomalies (26 per 1000 livebirths [3.0-90.0]) and musculoskeletal anomalies (38 per 1000 [8.0-109.0]) were predominant.
Medical subject headings
- Abnormalities, Drug-Induced
- Hallucinogens
- N-Methyl-3,4-methylenedioxyamphetamine